People · Operator
Named in public records as an officer, director or promoter · active 2009–2015 · Biotechnology, Other Energy, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MyoKardia Inc | — | Biotechnology | Series C | $60.0M | $1.9B | 2014 |
| Aerovance Inc | — | Biotechnology | Series B | $22.5M | $19.8M | 2009 |
| Pathway Therapeutics, Inc. | — | Biotechnology | Series A | $16.9M | $14.5M | 2012 |
| Glacier Bay, Inc. | — | Other Energy | Series A | $16.3M | $126.8M | 2009 |
| Prostor Systems Inc | — | Other Technology | Series A | $5.5M | $152.6M | 2010 |
| newScale Inc | — | Other Technology | Seed | $2.2M | $73.6M | 2009 |
Mark Perry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Perry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Walker | 1 | 17 |
| Ron Bernal | 1 | 10 |
| Peter Roshko | 1 | 6 |
| Michael Dorsey | 1 | 5 |
| Farah Champsi | 1 | 5 |
| Kevin Starr | 1 | 5 |
| Paul Goddard | 1 | 4 |
| Charles Homcy | 1 | 4 |
| Douglas E. Williams | 1 | 4 |
| Mark Harvey | 1 | 3 |
| Joshua Funder | 1 | 3 |
| Nick Galakatos | 1 | 3 |
| Duane Zitzner | 1 | 3 |
| Katherine Bowdish | 1 | 3 |
| Alain Schreiber | 1 | 3 |
| Scott Hammond | 1 | 2 |
| ANTHONY RIMAC | 1 | 2 |
| Julie Cherrington | 1 | 2 |
| Will Charles | 1 | 2 |
| Steve Georgis | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.